Live Breaking News & Updates on பிரஷண்ட் மாலி

Stay updated with breaking news from பிரஷண்ட் மாலி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Seattle-based Shape Therapeutics raises $112M to develop RNA-editing and gene therapies


Seattle-based Shape Therapeutics raises $112M to develop RNA-editing and gene therapies
Geekwire
3 hrs ago
© Provided by Geekwire
Shape CEO Francois Vigneault. (Shape Photo)
Shape Therapeutics, a Seattle preclinical stage biotech company developing RNA editing and gene therapy technologies, has raised $112 million.
The company’s RNA editing technologies are spun out of the lab of co-founder Prashant Mali, a bioengineer at the University of California, San Diego who is on Shape’s scientific advisory board. Shape is also improving methods to deliver genetic material into cells.
“We continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases,” said CEO and co-founder Francois Vigneault, former VP of research at Juno Therapeutics, a Seattle flagship cell therapy company that was acquired by Celgene in 2018. Other Juno veterans at the company include Adrian Briggs, head of platform technologies, an ....

United States , San Diego , Lou Gehrig , Francois Vigneault , Korro Bio , Don Cleveland , David Huss , Hadrian Briggs , University Of California , Enterprise Associates , Breakthrough Prize In Life Sciences , Mission Biocapital , Shape Photo , Geekwire Shape , Prashant Mali , Juno Therapeutics , Shape Therapeutic , Shape Graphic , Geekwire Shape Therapeutic , Breakthrough Prize , Life Sciences , Affinia Therapeutics , Beam Therapeutics , Decheng Capital , Breton Capital , Willett Advisors ,